Prospective Registry of Histotripsy for Soft Tissue Tumors
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of California, San Francisco
About this trial
Histotripsy is a treatment that uses focused ultrasound waves to break down tissue without surgery. The ultrasound waves meet at a specific spot and turn the tissue into liquid. This study is a prospective observational registry of participants receiving histotripsy. The goal of this study is to gather information about the use of histotripsy to confirm it is safe and effective medical procedure.
Eligibility criteria
Qualifiers
All adult patients who are treated with histotripsy per standard clinical care at University of California San Francisco (UCSF) are eligible for inclusion in the registry.
Disqualifiers
Children/minors, and adults who lack decision-making capacity, will be excluded from the registry. Patients who do not consent for inclusion in the registry will also be excluded.
Trial design
Treatments tested in this trial
- Medical Record Review
Treatment groups
200 Participants
are divided into 1 treatment groupLocations
1University of California, San Francisco94143, San FranciscoCalifornia, United States
Sponsors and collaborators
University of California, San Francisco
Lead sponsor
Source ClinicalTrials.gov